In a Newsweek opinion piece, Polly Price, an author and law professor at Emory University, examines the evolving threat of tuberculosis (TB) — “not only in the developing world, but also inside the United States, where the [CDC] recorded nearly 10,000 cases of TB last year.” She highlights the issue of drug resistance, examining the spread of and treatment options for “ordinary” TB, extensively drug-resistant tuberculosis (XDR-TB), and multidrug-resistant tuberculosis (MDR-TB). She discusses funding issues, noting, “TB treatment is time-consuming and expensive, even for the most routine, nonresistant occurrences of the disease.” She adds, “Public health is always ‘local,’ in the sense that it’s primarily about individuals, their loved ones, and communities. But preventing epidemics requires a broader vision and long-term investment” (11/26).